← Back to Clinical Trials
Recruiting NCT03097081

NCT03097081 ORthosis vs No Orthosis After Surgically Treated Traumatic Thoracolumbar Fractures

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03097081
Status Recruiting
Phase
Sponsor Amsterdam UMC, location VUmc
Condition Spine Fracture
Study Type INTERVENTIONAL
Enrollment 45 participants
Start Date 2016-11
Primary Completion 2025-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
No orthosisOrthosis

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 45 participants in total. It began in 2016-11 with a primary completion date of 2025-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Rationale: There is no evidence in the current literature regarding the additional value of an orthosis after surgically treated thoracolumbar spine fractures. Objective: To assess whether an orthosis provides additional pain relief compared to no orthosis after posteriorly fixated thoracolumbar spine fractures. Primary outcome is difference in pain at six weeks post-operatively. Secondary objectives are pain at other moments, pain medication used, pain related disability, quality of life, long-term kyphosis, possible complications, hospital stay, return to work and subjective feeling on benefit or disadvantage from the orthosis. Study design: Randomized controlled intervention study, non-inferiority trial. Study population: Dutch speaking patients presented at the VU university medical centre, 18 - 65 years old with a traumatic thoracolumbar spine fracture from Th7 - L4 surgically treated by posterior fixation. Intervention: One group receives standard care and wears an orthosis after surgery for 12 weeks, to use when in vertical position. The intervention group does not wear an orthosis after surgery. Main study parameters/endpoints: Main study outcome is the difference in pain noted on the NRS-score at six weeks, ≥ 2 (SD 2,5) change corresponds with a clinically significant change in pain score. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The current guideline for postoperative care regarding dorsal stabilization of spine fractures recommends the use of a post-operative orthosis. While patients generally receive an orthosis for 12 weeks, individual surgeon's believes sometimes gives reason to deviate from this guideline. This is founded by literature that increasingly questions the use of orthoses in the conservative treatment of spine fractures. With the fracture operatively stabilized, the orthosis mainly provides support of gesture and thereby potentially results in pain relief and confidence for patients. On the other hand some patients have a hard time weaning from the orthosis or report discomfort due to the device and prefer not to use it. With subjects being randomized between the use of an orthosis or no orthosis there is no additional risk. This is in part because it is hypothesized that there is no difference in postoperative pain and there might be a lower risk of complications related to the orthosis.

Eligibility Criteria

Inclusion Criteria: * Age 18 - 65 years * Traumatic thoracolumbar spine fracture from thoracic 7 - lumbar 4 * AO fracture types A-C * Undergoing surgical dorsal fixation for fracture Exclusion Criteria: * Inadequate knowledge of Dutch language or to fill in questionnaire * Complete or partial spinal cord injury (ASIA A to D) * (Additional) anterior surgical stabilization * Thoracolumbar fracture of other aetiology than traumatic, e.g. pathologic, infectious * Not able to walk before fracturing vertebra * Unable to come to the outpatient clinic (e.g. residing outside the Netherlands) * Injury Severity Score (ISS) ≥ 16 * Brain injury with Abbreviated Injury Score (AIS) ≥ 4 * Solitary Lumbar 5 fracture * Inability to wear an orthosis, most probable reasons: * BMI \> 35 * Thoraco-abdominal wounds (through trauma or secondary from surgery) on places at which the orthosis contacts the body so aggravation of pain or chances of infection increase significantly. 12 of 27 * Pre-existing spine deformities (scoliosis or very severe kyphosis/lordosis) which impair the use of the orthosis or aggravate pain.

Contact & Investigator

Central Contact

Frequently Asked Questions

Who can join the NCT03097081 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Spine Fracture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT03097081 currently recruiting?

Yes, NCT03097081 is actively recruiting participants. Contact the research team at aj.smits@amsterdamumc.nl for enrollment information.

Where is the NCT03097081 trial being conducted?

This trial is being conducted at Amsterdam, Netherlands.

Who is sponsoring the NCT03097081 clinical trial?

NCT03097081 is sponsored by Amsterdam UMC, location VUmc. The trial plans to enroll 45 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology